
Hosted by Johnson & Johnson, this event explores how automation and real-time analytics can shorten the vein-to-vein timeline in CAR-T cell therapy—enhancing access, reducing costs, and improving patient outcomes.
Speakers from Johnson & Johnson, NecstGen, Cellular Origins, SymCel, and NanoCell Tx will share innovations aimed at streamlining manufacturing, quality control, and scalability in cell and gene therapy.
The session will be held in Utrecht (venue to be confirmed) and can also be attended virtually. Participation can be combined with the Oncode Accelerator Summit at Jaarbeurs Utrecht in the afternoon.
Join our newsletter and get the latest news